CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Dialysis patient service revenues	$ 3,206,871	$ 3,061,102	$ 6,309,864	$ 6,002,634
Other revenues	172,655	125,620	293,191	254,643
Total revenues	3,379,526	3,186,722	6,603,055	6,257,277
Operating expenses:
Patient care costs	2,261,540	2,142,299	4,501,200	4,221,275
General and administrative	412,805	367,845	786,895	730,325
Depreciation and amortization	174,704	175,661	351,155	362,744
Equity investment income, net	(7,364)	(5,481)	(12,973)	(12,163)
Gain on changes in ownership interests	0	0	0	(35,147)
Total operating expenses	2,841,685	2,680,324	5,626,277	5,267,034
Operating income	537,841	506,398	976,778	990,243
Debt expense	(146,062)	(97,747)	(281,117)	(197,165)
Debt prepayment, extinguishment and modification costs	0	(9,732)	0	(9,732)
Other loss, net	(22,851)	(27,479)	(40,400)	(40,120)
Income before income taxes	368,928	371,440	655,261	743,226
Income tax expense	93,708	71,688	147,825	137,494
Net income	275,220	299,752	507,436	605,732
Less: Net income attributable to noncontrolling interests	(75,883)	(77,076)	(145,182)	(143,407)
Net income attributable to DaVita Inc.	$ 199,337	$ 222,676	$ 362,254	$ 462,325
Earnings per share attributable to DaVita Inc.:
Basic net income	$ 2.62	$ 2.56	$ 4.67	$ 5.29
Diluted net income	$ 2.58	$ 2.50	$ 4.57	$ 5.15
Weighted average shares for earnings per share:
Basic shares	75,943,000	86,899,000	77,646,000	87,337,000
Diluted shares	77,362,000	88,950,000	79,309,000	89,749,000